📊 Score Breakdown
Offering Ability
30
Cash Runway
65
Float Risk
87
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
34%
🔄 Reverse Split
40%
• 50-day avg $1.25 approaching $1 threshold
• 7 months cash with weak price
💰 Capital Raise
33%
• Under 12 months cash (7mo)
• Active ATM program with $70M remaining capacity
📉 Score Deterioration
25%
• Score increased 12 points recently (worsening)
💹 Market Data
Market Cap$9.21M
Shares Outstanding391.18M
Float36.03M
Cash$233.2K
Debt$1.88M
Short InterestN/A
🏛 Institutional Holdings
8 institutional holders · 97.6K shares
#1
Citadel Advisors Llc
46.0K shares
#2
Geode Capital Management, LLC
19.7K shares
#3
Vanguard Group Inc
14.6K shares
+ 5 more holders Sign up free to view →
📉 Short Interest
Short Interest562.5K
Days to Cover1.0
% of Float1.6%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
8-K
8K EVENT
Apr 24, 2026
424B5
ATM
Apr 02, 2026
8-K
8K EVENT
Apr 02, 2026
8-K
8K EVENT
Feb 19, 2026
8-K
8K EVENT
Feb 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CTNT
📊 CTNT FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CTNT Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.